PHARMACIA AND UPJOHN FDA Approval NDA 050689

NDA 050689

PHARMACIA AND UPJOHN

FDA Drug Application

Application #050689

Documents

Letter2001-11-09
Letter2015-07-09
Label2008-06-05
Letter2001-11-09
Letter2008-05-14
Letter2014-11-14
Label2003-05-07
Label2014-12-02
Label2015-07-06
Letter2021-03-09
Label2021-03-09
Letter2021-09-17
Label2021-09-20

Application Sponsors

NDA 050689PHARMACIA AND UPJOHN

Marketing Status

Prescription001

Application Products

001CAPSULE;ORAL150MG1MYCOBUTINRIFABUTIN

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1992-12-23PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1993-07-28
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1993-06-22
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1995-09-08
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1994-05-31
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1994-06-06
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1996-01-11
LABELING; LabelingSUPPL8AP1995-11-03STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1996-09-13
LABELING; LabelingSUPPL11AP2001-11-09STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1999-01-15
LABELING; LabelingSUPPL13AP2001-11-09STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL14AP2001-01-29
LABELING; LabelingSUPPL16AP2008-05-14STANDARD
LABELING; LabelingSUPPL18AP2014-11-13STANDARD
LABELING; LabelingSUPPL22AP2015-07-01STANDARD Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.
LABELING; LabelingSUPPL25AP2021-03-08STANDARD
LABELING; LabelingSUPPL26AP2021-09-15STANDARD

Submissions Property Types

ORIG1Null39
SUPPL2Null14
SUPPL3Null14
SUPPL4Null14
SUPPL5Null14
SUPPL6Null14
SUPPL7Null14
SUPPL10Null14
SUPPL12Null14
SUPPL14Null14
SUPPL16Null4
SUPPL18Null15
SUPPL22Null6
SUPPL25Null6
SUPPL26Null6

TE Codes

001PrescriptionAB

CDER Filings

PFIZER
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 50689
            [companyName] => PFIZER
            [docInserts] => ["",""]
            [products] => [{"drugName":"MYCOBUTIN","activeIngredients":"RIFABUTIN","strength":"150MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"09\/15\/2021","submission":"SUPPL-26","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2021\\\/050689s026lbl.pdf\"}]","notes":""},{"actionDate":"03\/08\/2021","submission":"SUPPL-25","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2021\\\/050689s025lbl.pdf\"}]","notes":""},{"actionDate":"07\/01\/2015","submission":"SUPPL-22","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/050689s022lbl.pdf\"}]","notes":"Please see"},{"actionDate":"11\/13\/2014","submission":"SUPPL-18","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/050689Orig1s018lbl.pdf\"}]","notes":""},{"actionDate":"05\/14\/2008","submission":"SUPPL-16","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/050689s016lbl.pdf\"}]","notes":""},{"actionDate":"11\/09\/2001","submission":"SUPPL-11","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2001\\\/50689s11s13lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"MYCOBUTIN","submission":"RIFABUTIN","actionType":"150MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2021-09-15
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.